Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Zenotech Laboratories Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of various medical products. Notably, its production activities include granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony-stimulating factor (GMCSF). The company's range of injectable offerings is strategically targeted at niche therapeutic areas such as oncology (cancer treatment) and anesthesiology. Founded on June 15, 1989, Zenotech Laboratories Ltd. maintains its headquarters in Hyderabad, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.